103 related articles for article (PubMed ID: 12437309)
1. Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices.
Walsh MN; Simpson RJ; Wan GJ; Weiss TW; Alexander CM; Markson LE; Berger ML; Pearson TA
Am J Manag Care; 2002 Nov; 8(11):937-46. PubMed ID: 12437309
[TBL] [Abstract][Full Text] [Related]
2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
3. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists.
Miller SW; Darsey E; Heard TJ; Williams J; Kelly M; Norman A; Ter Riet LB
Consult Pharm; 2010 Feb; 25(2):105-16. PubMed ID: 20211823
[TBL] [Abstract][Full Text] [Related]
5. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
Koren MJ; Hunninghake DB;
J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
[TBL] [Abstract][Full Text] [Related]
7. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
8. Achieving cholesterol target in a managed care organization (ACTION) trial.
Straka RJ; Taheri R; Cooper SL; Smith JC
Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283
[TBL] [Abstract][Full Text] [Related]
9. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
10. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
11. The impact of automatic prescriptions on reducing low-density lipoprotein cholesterol levels.
Siskind A; Johnson M; Qureshi A; Solow B; Chesebro D; Oldham N
Eff Clin Pract; 2000; 3(5):240-6. PubMed ID: 11185329
[TBL] [Abstract][Full Text] [Related]
12. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
[TBL] [Abstract][Full Text] [Related]
13. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
[TBL] [Abstract][Full Text] [Related]
14. Follow-up in a lipid clinic improves the management of risk factors in cardiovascular disease patients.
Gavish D; Leibovitz E; Elly I; Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Sep; 4(9):694-7. PubMed ID: 12440233
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease.
Lichtman JH; Amatruda J; Yaari S; Cheng S; Smith GL; Mattera JA; Roumanis SA; Wang Y; Radford MJ; Krumholz HM
Am Heart J; 2004 Mar; 147(3):522-8. PubMed ID: 14999204
[TBL] [Abstract][Full Text] [Related]
19. National improvements in low-density lipoprotein cholesterol management of individuals at high coronary risk: National Health and Nutrition Examination Survey, 1999 to 2002.
Cullen MW; Stein JH; Gangnon R; McBride PE; Keevil JG
Am Heart J; 2008 Aug; 156(2):284-91. PubMed ID: 18657658
[TBL] [Abstract][Full Text] [Related]
20. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
